Want to join the conversation?
During 1Q16, the use of lab core data played a key role in winning a large Phase III oncology study which increased $LH's cumulative orders from use of lab core data to over $190MM. The company has begun to convert this backlog into revenue and remains on track to deliver $150MM in incremental revenue through 2018.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.